• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从医院到家庭:针对心力衰竭恶化的循证护理

From Hospital to Home: Evidence-Based Care for Worsening Heart Failure.

作者信息

Oskouie Suzanne, Pandey Ambarish, Sauer Andrew J, Greene Stephen J, Mullens Wilfried, Khan Muhammad Shahzeb, Quinn Kieran L, Ho Jennifer E, Albert Nancy M, Van Spall Harriette Gc

机构信息

Division of Cardiology, University of Arizona Sarver Heart Center, Tucson, Arizona, USA.

Division of Cardiology, UT Southwestern Medical Center, Dallas, Texas, USA.

出版信息

JACC Adv. 2024 Jul 31;3(9):101131. doi: 10.1016/j.jacadv.2024.101131. eCollection 2024 Sep.

DOI:10.1016/j.jacadv.2024.101131
PMID:39184855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11342447/
Abstract

Heart failure (HF) is a leading cause of hospitalization in older adults. Patients are at high risk of readmission and death following hospitalization for HF. There is no standard approach of health care delivery during the hospital-to-home transition period, leaving missed opportunities in care optimization. In this review, we discuss contemporary randomized clinical trials that tested decongestion strategies, disease-modifying therapies, and health care services that inform the care of patients with worsening HF. We provide evidence-informed recommendations for optimizing therapies and improving outcomes during and following hospitalization for HF. These include adequate decongestion with loop diuretics and select sequential nephron blockade strategies based on early evaluation of diuretic response; initiation of disease-modifying pharmacotherapies prior to hospital discharge with close follow-up and optimization after discharge; cardiac rehabilitation; and transitional or palliative care referral post-hospitalization. Evidence-based implementation strategies to facilitate broad uptake include digital health tools and algorithm-driven optimization of pharmacotherapies.

摘要

心力衰竭(HF)是老年人住院治疗的主要原因。心力衰竭患者住院后再入院和死亡风险很高。在从医院过渡到家庭的期间,没有标准的医疗服务提供方式,导致在优化护理方面错失机会。在本综述中,我们讨论了当代随机临床试验,这些试验测试了用于治疗病情恶化的心力衰竭患者的去充血策略、疾病改善疗法和医疗服务。我们提供基于证据的建议,以优化治疗方法并改善心力衰竭患者住院期间及出院后的治疗效果。这些建议包括使用袢利尿剂进行充分的去充血,并根据对利尿剂反应的早期评估选择序贯肾单位阻断策略;在出院前开始使用疾病改善药物治疗,并在出院后密切随访和优化;心脏康复;以及出院后转诊至过渡性或姑息性护理。促进广泛采用的基于证据的实施策略包括数字健康工具和药物治疗的算法驱动优化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/1ce2881f4092/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/1ce2881f4092/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/b94355236fb5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/d34debecdac0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/d6ab0ac45207/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/1ce2881f4092/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/1ce2881f4092/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/b94355236fb5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/d34debecdac0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/d6ab0ac45207/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a894/11342447/1ce2881f4092/gr4.jpg

相似文献

1
From Hospital to Home: Evidence-Based Care for Worsening Heart Failure.从医院到家庭:针对心力衰竭恶化的循证护理
JACC Adv. 2024 Jul 31;3(9):101131. doi: 10.1016/j.jacadv.2024.101131. eCollection 2024 Sep.
2
Effects of a transitional palliative care model on patients with end-stage heart failure: study protocol for a randomized controlled trial.过渡性姑息治疗模式对终末期心力衰竭患者的影响:一项随机对照试验的研究方案
Trials. 2016 Mar 31;17:173. doi: 10.1186/s13063-016-1303-7.
3
In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.因心力衰竭恶化住院患者的院内利尿剂使用及出院后临床结局:来自EVEREST试验的见解
JACC Heart Fail. 2016 Jul;4(7):580-588. doi: 10.1016/j.jchf.2016.02.008. Epub 2016 Mar 30.
4
Community-based care for the specialized management of heart failure: an evidence-based analysis.基于社区的心力衰竭专科管理:一项循证分析
Ont Health Technol Assess Ser. 2009;9(17):1-42. Epub 2009 Nov 1.
5
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).急性心力衰竭住院期间及出院后充血症状的缓解与复发:急性失代偿性心力衰竭利尿优化策略评估(DOSE-AHF)及急性失代偿性心力衰竭心肾挽救研究(CARESS-HF)的见解
Circ Heart Fail. 2015 Jul;8(4):741-8. doi: 10.1161/CIRCHEARTFAILURE.114.001957. Epub 2015 Jun 3.
6
Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study.当代心力衰竭住院患者的去充血策略:一项基于全国社区的队列研究。
JACC Heart Fail. 2024 Aug;12(8):1381-1392. doi: 10.1016/j.jchf.2024.04.002. Epub 2024 Apr 7.
7
Exercise-based cardiac rehabilitation for adults with heart failure.针对成年心力衰竭患者的运动心脏康复治疗。
Cochrane Database Syst Rev. 2019 Jan 29;1(1):CD003331. doi: 10.1002/14651858.CD003331.pub5.
8
Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction.针对左心室射血分数不同阶段的新发或恶化心力衰竭住院患者的治疗策略不断演变。
Clin Cardiol. 2022 Jun;45 Suppl 1(Suppl 1):S40-S51. doi: 10.1002/clc.23849.
9
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.急性心力衰竭中的充血消除策略与肾素-血管紧张素-醛固酮系统激活
JACC Heart Fail. 2015 Feb;3(2):97-107. doi: 10.1016/j.jchf.2014.09.003. Epub 2014 Oct 31.
10
Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature.静脉和皮下注射利尿剂用于门诊治疗失代偿性心力衰竭:文献系统综述
ESC Heart Fail. 2020 Jun;7(3):892-902. doi: 10.1002/ehf2.12677. Epub 2020 Mar 11.

引用本文的文献

1
Semaphorin 3F is elevated in serum of heart failure patients and inhibits cardiac angiogenesis via the VEGF/Akt/eNOS pathway.信号素3F在心力衰竭患者血清中升高,并通过VEGF/Akt/eNOS途径抑制心脏血管生成。
J Mol Cell Cardiol Plus. 2025 Jun 25;13:100470. doi: 10.1016/j.jmccpl.2025.100470. eCollection 2025 Sep.
2
Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review.针对心肾疾病患者的指南推荐疾病改善疗法:行动呼吁叙述性综述
Adv Ther. 2025 May 28. doi: 10.1007/s12325-025-03228-1.

本文引用的文献

1
Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes.射血分数降低的心力衰竭患者的压力反射激活疗法:长期疗效。
Eur J Heart Fail. 2024 Apr;26(4):1051-1061. doi: 10.1002/ejhf.3232. Epub 2024 Apr 12.
2
Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial.晚期心力衰竭的房间隔分流治疗:RELIEVE-HF试验开放标签队列的结果
Eur J Heart Fail. 2024 Apr;26(4):1078-1089. doi: 10.1002/ejhf.3215. Epub 2024 Apr 1.
3
Effect of a transitional care model following hospitalization for heart failure: 3-year outcomes of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) randomized controlled trial.
心力衰竭患者住院后过渡护理模式的效果:心力衰竭患者以患者为中心的护理过渡(PACT-HF)随机对照试验的 3 年结果。
Eur J Heart Fail. 2024 Mar;26(3):652-660. doi: 10.1002/ejhf.3134. Epub 2024 Feb 1.
4
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).心力衰竭患者植入式装置治疗的整合。欧洲心脏病学会(ESC)心力衰竭协会(HFA)和欧洲心律协会(EHRA)的临床共识声明。
Eur J Heart Fail. 2024 Feb;26(2):483-501. doi: 10.1002/ejhf.3150. Epub 2024 Jan 25.
5
Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model.通用心脏病药物价格:马克·库班成本加成制药公司模式的潜在益处
Front Pharmacol. 2023 Aug 22;14:1179253. doi: 10.3389/fphar.2023.1179253. eCollection 2023.
6
Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial.利尿剂治疗急性心力衰竭的利钠尿肽指导:一项实用随机试验。
Nat Med. 2023 Oct;29(10):2625-2632. doi: 10.1038/s41591-023-02532-z. Epub 2023 Aug 28.
7
Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function.达格列净治疗伴有肾功能恶化的心力衰竭患者。
J Am Coll Cardiol. 2023 Nov 7;82(19):1854-1863. doi: 10.1016/j.jacc.2023.08.026. Epub 2023 Aug 25.
8
Ferric Carboxymaltose in Heart Failure with Iron Deficiency.铁羧基麦芽糖在缺铁性心力衰竭中的应用。
N Engl J Med. 2023 Sep 14;389(11):975-986. doi: 10.1056/NEJMoa2304968. Epub 2023 Aug 26.
9
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.《2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》2023年聚焦更新
Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195.
10
Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF.首次心力衰竭住院后死亡率、结局、成本和药物使用:EVOLUTION HF。
JACC Heart Fail. 2023 Oct;11(10):1320-1332. doi: 10.1016/j.jchf.2023.04.017. Epub 2023 Jun 21.